{
    "Trade/Device Name(s)": [
        "Aptiva CTD Essential Reagent"
    ],
    "Submitter Information": "Inova Diagnostics, Inc.",
    "510(k) Number": "K213403",
    "Predicate Device Reference 510(k) Number(s)": [
        "K152013",
        "K123593",
        "K954830",
        "K141655",
        "K141328",
        "K141210",
        "K152635",
        "K151429",
        "K123880",
        "K981237"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL",
        "LJM",
        "LKP",
        "LKO",
        "LSW",
        "MQA",
        "OBE"
    ],
    "Summary Letter Date": "February 24, 2023",
    "Summary Letter Received Date": "February 24, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "dsDNA",
        "RNP",
        "Sm",
        "Ro52",
        "Ro60",
        "SS-B",
        "Scl-70",
        "Jo-1",
        "Centromere",
        "Ribo-P"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Inova Diagnostics Aptiva System",
        "Aptiva Multi-Analyte Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-based multi-analyte technology (PMAT)",
        "Solid phase immunoassay",
        "Fluorescent immunoassay"
    ],
    "Methodologies": [
        "Multiplexed immunoassay",
        "Particle-based immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay",
        "Kit",
        "Multiplex"
    ],
    "Document Summary": "FDA 510(k) summary for Aptiva CTD Essential Reagent, a multiplexed particle-based immunoassay panel for IgG autoantibody detection in serum related to connective tissue diseases using the Aptiva platform.",
    "Indications for Use Summary": "Multiplexed immunoassays for quantitative and semi-quantitative determination of IgG autoantibodies (dsDNA, RNP, Sm, Ro52, Ro60, SS-B, Scl-70, Jo-1, centromere, Ribo-P) in serum as an aid in diagnosing systemic lupus erythematosus, mixed connective tissue disease, Sj\u00f6gren\u2019s syndrome, systemic sclerosis, idiopathic inflammatory myositis, used with the Aptiva system.",
    "fda_folder": "Immunology"
}